Saxenda, a GLP-1 receptor agonist licensed in the UK for obesity and overweight with comorbidities, is not officially associated with acne in its Summary of Product Characteristics or clinical trial data
42,44 Women should obtain advice from their healthcare provider before beginning any physical activity
When you sign up, you get a personalized plan that may include prescription drugs, nutrition advice, exercise plans, and regular check-ins
For other patients, an injection every three to four months may suffice
Lee E et al
While only your provider can determine whether semaglutide for weight loss is appropriate for you, people who may be considered for GLP-1 therapy often include adults who: Have obesity (often defined as BMI 30), or Have overweight (BMI 27) with weight-related conditions such as high blood pressure, type 2 diabetes, or high cholesterol Are ready to pair medication with nutrition, movement, and lifestyle changes Prefer a non-surgical medical weight loss approach Semaglutide is prescription-only, and it is not suitable for everyone